These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 18070122

  • 1. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver.
    Singha J, Khan K, Chatterjee S.
    Indian J Pathol Microbiol; 2018 Jan; 61(4):510-515. PubMed ID: 30303139
    [Abstract] [Full Text] [Related]

  • 5. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C, Licht J, Roessner A, Carl-McGrath S.
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA, Yazdi HM.
    Acta Cytol; 1990 Dec; 34(2):192-6. PubMed ID: 2157322
    [Abstract] [Full Text] [Related]

  • 11. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 12. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS, Pomjanski N, Buckstegge B, Böcking A.
    Cancer; 2007 Aug 25; 111(4):259-68. PubMed ID: 17567831
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2009 Sep 25; 37(9):629-35. PubMed ID: 19405109
    [Abstract] [Full Text] [Related]

  • 16. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S.
    Diagn Cytopathol; 2009 Mar 25; 37(3):184-90. PubMed ID: 19170172
    [Abstract] [Full Text] [Related]

  • 17. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.
    Am J Surg Pathol; 2008 Mar 25; 32(3):433-44. PubMed ID: 18300806
    [Abstract] [Full Text] [Related]

  • 18. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul 25; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 19. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP, Macchia S, Baccarini P, Milandri GL, Losi L, Spongano P, Panarelli M, Dal Monte PR, Eusebi V.
    Pathologica; 1999 Aug 25; 91(4):260-7. PubMed ID: 10630075
    [Abstract] [Full Text] [Related]

  • 20. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH, Hughes JH, De Young BR.
    Cancer; 1999 Oct 25; 87(5):295-8. PubMed ID: 10536355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.